Voting period for this idea type has passed

Does Size Healthcare?

Can the small stuff scale in health? When many of our largest health care issues are systemic or policy driven, what’s needed to truly transform our ecosystem and drive lasting change? Do health start-ups have what it takes? Can they get it? How?

It's gospel with tech start-ups that you should focus on scale first and foremost. In healthcare, it's the opposite. Traditional drug and medical device companies focus on validating effectiveness, and rely on larger acquirers to take a new technology to scale.

What's the right model for tech companies in health? Should start-ups be focused on scale or effectiveness first and foremost?

Sue Siegel, current CEO of Healthymagination at GE (and former health care VC); Aman Bhandari, Senior Advisor to Todd Park at the White House; Geoff Clapp, mentor at Rock Health/former entrepreneur; and Martha Wofford, VP at Aetna, running CarePass, will debate issues of scale, scope and impact...and the road to working together to get this right.

Additional Supporting Materials




Elliot Cohen, Co-Founder/Co-Director, MIT Hacking Medicine

Add Comments

comments powered by Disqus

SXSW reserves the right to restrict access to or availability of comments related to PanelPicker proposals that it considers objectionable.

Show me another